Ziprasidone belongs to a class of medications known as typical antipsychotics, which are generally used to treat schizophrenia and manic depression. Schizophrenia is a mental illness in which a person may feel, hear, or see things that are not there, believe falsehoods, and have extraordinary suspicion or confusion. Manic depression, often known as bipolar illness, is a significant brain condition characterized by strong mood swings as well as frequent mood and behavioral changes. It works by suppressing the effects of chemical messengers in the brain, improving thinking, mood, and behavior; it promotes clear thinking and reduces hallucinations. It is used to treat manic periods of bipolar illness as well as agitation in schizophrenia. The FDA authorized Ziprasidone in 2001.
BRAND NAMES
Zeldox –It contains the active ingredients of Ziprasidone. It is available in the form of tablets used to treat schizophrenia and bipolar disorder.
Geodon- It contains the active ingredients of Ziprasidone. It is available in the form of capsules.
MECHANISM OF ACTION
Ziprasidone is an atypical antipsychotic that binds to dopaminergic, serotonergic, adrenergic, and histamine receptors. It also shows minimal action on the norepinephrine and serotonin transporters. Antagonizing histaminergic and adrenergic receptors can cause drowsiness and orthostatic hypotension. In terms of schizophrenia therapy, antagonism of the dopamine receptor in the mesolimbic pathways is effective in reducing positive symptoms, but antagonism of the 5H2A receptor in the mesocortical route reduces negative symptoms of psychosis. The drug's effectiveness and mode of action for treating bipolar disorder remain uncertain.
PHARMACOKINETICS
Absorption
Oral formation Tmax is around 6 to 8 hours. Within 1 to 3 days of treatment, plasma concentrations reach steady-state levels. When taken orally with meals, the bioavailability is around 70 percent. IM dosing provides close to 100% bioavailability. The IM formulation shortens the time required to achieve peak plasma concentration.
Distribution
Ziprasidone's mean apparent volume of distribution is 1.5 liters per kilogram.
Metabolism
Glutathione and aldehyde oxidase mediate the major metabolism of ziprasidone; CYP1A2 and CYP3A4 play a small part in this process. Benzothiazole sulfoxide and benzothiazole sulfone are among the active metabolites produced.
Excretion
A minimal amount of Ziprasidone is excreted in the urine.
PHARMACODYNAMICS
Ziprasidone acted as an antagonist at the D2, 5H2A, and 5HT1D receptors and an agonist at the 5HT1A receptor. Ziprasidone decreased serotonin and norepinephrine reuptake at synapses. Other receptor/binding sites tested showed no significant affinity, including the cholinergic muscarinic receptor.
DOSAGE AND ADMINISTRATION
Ziprasidone is available as a capsule to be taken orally. It is often taken twice a day with food. Take ziprasidone at the same times every day.
It is available in capsules with doses of 20mg, 40mg, 60mg, and 80mg.
It is available in the form of powder for injection at a dosage of 20mg.
DRUG INTERACTIONS
Drug interactions with ziprasidone may include
Pain relievers – codeine and hydrocodone
Anti-anxiety drugs – alprazolam, lorazepam and zolpidem
Muscle relaxants – carisoprodol and cyclobenzaprine
Anti-allergic drugs – cetirizine
Common cold medicines – diphenhydramine
Antidepressants – escitalopram, fluoxetine and sertraline
Antipsychotics – quetiapine
Fits medicines – topiramate
CNS stimulates - lisdexamfetamine
CONTRAINDICATIONS
Patients having a recent acute myocardial infarction. Patients have a prior history of QT prolongation, including congenital long QT syndrome. Patients with uncompensated cardiac failure.
SIDE EFFECTS
Ziprasidone may cause side effects
Headache
Restlessness
Anxiety
Lack of energy
Constipation
Diarrhea
Loss of appetite
Muscle pain
Stomach pain
Runny nose
Cough
Weight gain
Decreased sexual ability
Some side effects can be serious
Fast, irregular, or pounding heartbeat
Itching
Rash
Mouth sores
Fever
Chills
Shaking
Muscle stiffness
Confusion
Sweating
Loss of consciousness
OVERDOSE
Symptoms of overdose may include the following
Drowsiness
Slurred speech
Sudden movements that you cannot control
Anxiety
Uncontrollable shaking of a part of the body
TOXICITY
Ziprasidone has a binding affinity for histamine H1 receptors, which can cause somnolence, especially at hazardous doses. Priapism, body temperature regulation, and suicide can all result from hazardous medication levels if proper patient and case management is done. An overdose ensures the patient's breathing, and intubation may be required. If the patient is unconscious, IV access is essential for doing gastric lavage intubation. Charcoal can also be used in conjunction with a laxative to help with medication clearance.